These findings are also supported by two recent human studies showing that MD adherence over 210 days or 24 weeks was associated with lower serum glucose, elevated fasting GLP-1 level, and improved insulin resistance and HgbA1c [94,95]. Here, GCG is linked to Insulin resistance.